| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.12 | 0.008 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.091 | 0.009 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |